D. E. Shaw & Co., Inc. Cyclerion Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.47 - $1.29 $57,457 - $157,701	-122,249 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $13,785 - $25,560	-14,360 Reduced 10.51%	122,249 $136,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $212,074 - $406,475	-135,945 Reduced 49.88%	136,609 $235,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $280,387 - $424,175	-102,706 Reduced 27.37%	272,554 $837,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.29 $668,797 - $1.32 Million	306,788 Added 448.05%	375,260 $1.46 Million
Q1 2021 May 17, 2021	SELL	$2.69 - $5.12 $303,472 - $577,612	-112,815 Reduced 62.23%	68,472 $191,000
Q4 2020 Feb 16, 2021	BUY	$2.25 - $7.12 $188,419 - $596,243	83,742 Added 85.85%	181,287 $555,000
Q3 2020 Nov 16, 2020	SELL	$3.46 - $8.39 $155,398 - $376,820	-44,913 Reduced 31.53%	97,545 $593,000
Q2 2020 Aug 14, 2020	BUY	$2.37 - $7.14 $131,207 - $395,284	55,362 Added 63.56%	142,458 $842,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $456,790 - $1.08 Million	-185,687 Reduced 68.07%	87,096 $231,000
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $293,126 - $2.19 Million	162,848 Added 148.13%	272,783 $742,000
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $2,435 - $4,362	300 Added 0.27%	109,935 $1.33 Million
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $1.05 Million - $2.51 Million	109,635 New	109,635 $1.26 Million

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $126M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.